Association of Schizophrenia with Fracture-related Femoral Neck Displacement: A Cross-sectional Retrospective Study

Overview

Journal PCN Rep

Publisher Wiley

Date 2024 Jun 13

PMID 38868087

Authors

Yukiyo Inoue

Akihiro Tokushige

Takeshi Kinjyo

Shinichiro Ueda

Affiliations

Soon will be listed here.

Abstract

Aim: Fracture-related femoral neck displacement is more likely in patients with schizophrenia because of delayed diagnosis, as these patients frequently have less severe fracture-associated subjective symptoms. This study aimed to investigate the association of schizophrenia with the risk of fracture-related femoral neck displacement in hospitalized patients.

Methods: We retrospectively analyzed the medical records of patients with femoral neck fractures treated between April 2013 and March 2018 at a single institution. Multivariate logistic regression was used to explore the relationship between schizophrenia and fracture-related femoral neck displacement after adjusting for risk factors.

Results: We compared 30 and 194 patients with and without schizophrenia, respectively. The prevalence of fracture-related displacement was 80.0% in patients with schizophrenia and 62.4% in the controls ( = 0.06). After adjusting for confounding variables, schizophrenia significantly correlated with fracture-related femoral neck displacement (odds ratio: 4.74, 95% confidence interval: 1.09-20.60, = 0.0378).

Conclusions: Schizophrenia is associated with a higher risk of severe femoral neck fracture. To improve outcomes and alleviate the societal burden of femoral neck fractures, early radiographic assessment and surgical intervention for femoral fractures are essential for patients with schizophrenia, even in those without pain symptoms.

Citing Articles

Association of schizophrenia with fracture-related femoral neck displacement: A cross-sectional retrospective study.

Inoue Y, Tokushige A, Kinjyo T, Ueda S PCN Rep. 2024; 3(2):e195.

PMID: 38868087 PMC: 11114322. DOI: 10.1002/pcn5.195.

References

Cramer J, Rosenheck R . Compliance with medication regimens for mental and physical disorders. Psychiatr Serv. 1998; 49(2):196-201. DOI: 10.1176/ps.49.2.196. View

De Hert M, Correll C, Bobes J, Cetkovich-Bakmas M, Cohen D, Asai I . Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry. 2011; 10(1):52-77. PMC: 3048500. DOI: 10.1002/j.2051-5545.2011.tb00014.x. View

Meyer J, Lehman D . Bone mineral density in male schizophrenia patients: a review. Ann Clin Psychiatry. 2006; 18(1):43-8. DOI: 10.1080/10401230500464687. View

Leucht S, Burkard T, Henderson J, Maj M, Sartorius N . Physical illness and schizophrenia: a review of the literature. Acta Psychiatr Scand. 2007; 116(5):317-33. DOI: 10.1111/j.1600-0447.2007.01095.x. View

Kishimoto T, De Hert M, Carlson H, Manu P, Correll C . Osteoporosis and fracture risk in people with schizophrenia. Curr Opin Psychiatry. 2012; 25(5):415-29. PMC: 3566242. DOI: 10.1097/YCO.0b013e328355e1ac. View

Meaney A, OKeane V . Bone mineral density changes over a year in young females with schizophrenia: relationship to medication and endocrine variables. Schizophr Res. 2007; 93(1-3):136-43. DOI: 10.1016/j.schres.2007.01.013. View

Stromberg L, Lindgren U, Nordin C, Ohlen G, Svensson O . The appearance and disappearance of cognitive impairment in elderly patients during treatment for hip fracture. Scand J Caring Sci. 1997; 11(3):167-75. DOI: 10.1111/j.1471-6712.1997.tb00450.x. View

Wu C, Chang C, Tsai Y, Huang Y, Tsai H . Antipsychotic treatment and the risk of hip fracture in subjects with schizophrenia: a 10-year population-based case-control study. J Clin Psychiatry. 2015; 76(9):1216-23. DOI: 10.4088/JCP.14m09098. View

Klement M, Bala A, Blizzard D, Wellman S, Bolognesi M, Seyler T . Should We Think Twice About Psychiatric Disease in Total Hip Arthroplasty?. J Arthroplasty. 2016; 31(9 Suppl):221-6. DOI: 10.1016/j.arth.2016.01.063. View

10.

LeBlanc K, Muncie Jr H, LeBlanc L . Hip fracture: diagnosis, treatment, and secondary prevention. Am Fam Physician. 2014; 89(12):945-51. View

11.

Takusari E, Sakata K, Hashimoto T, Fukushima Y, Nakamura T, Orimo H . Trends in Hip Fracture Incidence in Japan: Estimates Based on Nationwide Hip Fracture Surveys From 1992 to 2017. JBMR Plus. 2021; 5(2):e10428. PMC: 7872333. DOI: 10.1002/jbm4.10428. View

12.

OConnor M, Switzer J . AAOS Clinical Practice Guideline Summary: Management of Hip Fractures in Older Adults. J Am Acad Orthop Surg. 2022; 30(20):e1291-e1296. DOI: 10.5435/JAAOS-D-22-00125. View

13.

Halbreich U . Osteoporosis, schizophrenia and antipsychotics: the need for a comprehensive multifactorial evaluation. CNS Drugs. 2007; 21(8):641-57. DOI: 10.2165/00023210-200721080-00003. View

14.

Vestergaard P, Rejnmark L, Mosekilde L . Anxiolytics, sedatives, antidepressants, neuroleptics and the risk of fracture. Osteoporos Int. 2006; 17(6):807-16. DOI: 10.1007/s00198-005-0065-y. View

15.

Larrosa M, Gomez A, Casado E, Moreno M, Vazquez I, Orellana C . Hypovitaminosis D as a risk factor of hip fracture severity. Osteoporos Int. 2011; 23(2):607-14. DOI: 10.1007/s00198-011-1588-z. View

16.

Tsai K, Lee C, Chou Y, Shen S, Su C, Wu H . The risks of major osteoporotic fractures in patients with schizophrenia: a population-based 10-year follow-up study. Schizophr Res. 2014; 159(2-3):322-8. DOI: 10.1016/j.schres.2014.09.032. View

17.

Cauley J, Lui L, Genant H, Salamone L, Browner W, Fink H . Risk factors for severity and type of the hip fracture. J Bone Miner Res. 2008; 24(5):943-55. PMC: 2672209. DOI: 10.1359/jbmr.081246. View

18.

Stubbs B . Antipsychotic-induced hyperprolactinaemia in patients with schizophrenia: considerations in relation to bone mineral density. J Psychiatr Ment Health Nurs. 2009; 16(9):838-42. DOI: 10.1111/j.1365-2850.2009.01472.x. View

19.

Vancampfort D, Knapen J, Probst M, Scheewe T, Remans S, De Hert M . A systematic review of correlates of physical activity in patients with schizophrenia. Acta Psychiatr Scand. 2011; 125(5):352-62. DOI: 10.1111/j.1600-0447.2011.01814.x. View

20.

Sorensen H, Jensen S, Nielsen J . Schizophrenia, antipsychotics and risk of hip fracture: a population-based analysis. Eur Neuropsychopharmacol. 2013; 23(8):872-8. DOI: 10.1016/j.euroneuro.2013.04.002. View